Elborn JS, Davies J (2017) Clinical trial research in focus: ensuring new cystic fibrosis API fulfill their potential. Lancet Respir Med 5:681–683. https://doi.org/10.1016/S2213-2600(17)30311-9

Article  PubMed  Google Scholar 

Castellani C, Assael BM (2017) Cystic fibrosis: a clinical view. CMLS 74:129–140

Article  CAS  PubMed  Google Scholar 

Gentzsch M, Mall MA (2018) Ion channel modulators in cystic fibrosis. Chest 154:383–393

Article  PubMed  PubMed Central  Google Scholar 

Sondo E, Cresta F, Pastorino C, Tomati V, Capurro V, Pesce E, Lena M, Iacomino M, Baffico AM, Coviello D (2022) The L467F–F508del complex allele hampers pharmacological rescue of mutant CFTR by elexacaftor/tezacaftor/ivacaftor in cystic fibrosis patients: the value of the ex vivo nasal epithelial model to address non-responders to CFTR-modulating API. Int J Mol Sci 23:3175–3189

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marakatham S, Shanmugapandiyan P (2023) Stability indicating bioanalytical validation of elexacaftor, ivacaftor and tezacaftor using HPLC in human plasma. RJPT 16:3780–3786

Article  Google Scholar 

Özcan S, Can NÖ (2023) Determination of ivacaftor by liquid chromatography techniques in pharmaceutical formulation with interlaboratory comparison and characterization of five novel degradation products by high-performance liquid chromatography ion trap time-of-flight mass spectrometry. J Sep Sci 46:2201061

Article  Google Scholar 

Özcan S, Erdoğan UÜ, Levent S, Can NÖ (2023) Liquid chromatographic determination of lumacaftor in the presence of ivacaftor and identification of five novel degradation products using high-performance liquid chromatography ion trap time-of-flight mass spectrometry. J Sep Sci 46:2300228

Article  Google Scholar 

Pigliasco F, Cafaro A, Stella M, Baiardi G, Barco S, Pedemonte N, D’Orsi C, Cresta F, Casciaro R, Castellani C (2023) Simultaneous quantification of ivacaftor, tezacaftor, and elexacaftor in cystic fibrosis patients’ plasma by a novel LC–MS/MS method. Biomedicines 11:628–638

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tatavarti BK, Khatare KK (2023) HPLC method development and validation of ivacaftor and lumacaftor, characterization of its degradants by Lc-Ms/Ms. JNS History Politics Cult 33:5701–5723

Google Scholar 

Shivaradha B, Rani SS (2022) RP-HPLC method development and validation for the simultaneous determination of elexacaftor, ivacator and tezacaftor in pharmaceutical dosage forms. WJPS 10:1–37

Google Scholar 

Ryan KJ, Guimbellot JS, Dowell AE, Reed-Walker KD, Kerstner-Wood CD, Anderson JD, Liu Z, Acosta EP (2022) Quantitation of cystic fibrosis triple combination therapy, elexacaftor/tezacaftor/ivacaftor, in human plasma and cellular lysate. J Chromatogr B 1213:123518

Article  CAS  Google Scholar 

Vonk SE, van der Meer-Vos M, Bos LD, Neerincx AH, Majoor CJ, Maitland-van der Zee A-H, Mathôt RA, Kemper EM (2021) Quantitative method for the analysis of ivacaftor, hydroxymethyl ivacaftor, ivacaftor carboxylate, lumacaftor, and tezacaftor in plasma and sputum using liquid chromatography with tandem mass spectrometry and its clinical applicability. Ther Drug Monit 43:555–563

Article  CAS  PubMed  Google Scholar 

Yuan H, Yu S, Chai G, Liu J, Zhou QT (2021) An LC-MS/MS method for simultaneous analysis of the cystic fibrosis therapeutic API colistin, ivacaftor and ciprofloxacin. J Pharm Anal 11:732–738

Article  PubMed  PubMed Central  Google Scholar 

Habler K, Kalla A-S, Rychlik M, Bruegel M, Teupser D, Nährig S, Vogeser M, Paal M (2022) Isotope dilution LC-MS/MS quantification of the cystic fibrosis transmembrane conductance regulator (CFTR) modulators ivacaftor, lumacaftor, tezacaftor, elexacaftor, and their major metabolites in human serum. Clin Chem Lab Med 60:82–91

Article  CAS  PubMed  Google Scholar 

Panchakarla R, Ravi P, Mullangi S, Kondapalli V (2022) Liquid chromatography-mass spectrometric methods for trace quantification of potential genotoxic impurities in ivacaftor and lumacaftor. Ann Pharm Fr 80:448–459

Article  CAS  PubMed  Google Scholar 

Singh R, Omray L, Soni P (2021) New cost-effective RP-HPLC method development and validation for quantitative estimation of ivacaftor in pharmaceutical formulation. Int J Pharm Sci Rev Res 71:52–57

Article  CAS  Google Scholar 

Venkata MS, Rao AL, Carey MW (2021) Simultaneous estimation of ivacaftor and tezacaftor in rat plasma by liquid chromatography coupled with tandem-mass-spectrometry: application to pharmacokinetic studies. Thai J Pharm Sci 45:451–460

Article  Google Scholar 

Singh N, Bansal P, Maithani M, Chauhan Y (2020) Development and validation of a novel stability-indicating RP-HPLC method for simultaneous determination of tezacaftor and ivacaftor in fixed dose combination. J Chromatogr Sci 58:346–354

Article  CAS  PubMed  Google Scholar 

Donakonda M, Indrakanti S, Pasala PK, Desari M, Kammari S (2021) A rapid RP-HPLC method for the simultaneous estimation of ivacaftor and tezacaftor and in silico study of their metabolitic products. Future J Pharm Sci 7:1–14

Google Scholar 

Rao CP, Chandralekha RM (2021) Stability indicating validated method development for the simultaneous estimation of tezacaftor, ivacaftor & elexacaftor in API and pharmaceutical dosage form. World J Pharm Sci 9:125–143

Article  CAS  Google Scholar 

Ayyappa MR, Babu GR, Sushama C, Sowjanya M, Murthy GL (2019) A novel stability-indicating RP-HPLC method for the simultaneous analysis of ivacaftor and tezacaftor in pure and its pharmaceutical formulations. Int J Pharm Sci 9:172–183

Google Scholar 

Dastagiri J, Sivagami B, Chandrasekar R, Kumar VP, Hemalatha S, Gunasekar G (2019) Stability indicating RP-HPLC method for simultaneous estimation of lumacaftor and ivacaftor in bulk and pharmaceutical dosage form. J Pharm Sci Res 11:2898–2904

Google Scholar 

Laxmi PM, Bakshi A, Bhagavan RM (2019) New RP-HPLC method development and validation for simultaneous estimation and forced degradation studies of ivacaftor and tezacaftor in solid dosage form. World J Pharma Res 8:45–60

Google Scholar 

Priyadarshini GI, Mounika V, Anjani G, Sowmya B (2020) Stability indicating RP-HPLC method development and validation for the simultaneous estimation of tezacaftor and ivacaftor in bulk and pharmaceutical dosage form. Asian J Pharm Anal 10:19–26

Article  Google Scholar 

Schneider EK, Reyes-Ortega F, Li J, Velkov T (2017) Optimized LC-MS/MS method for the high-throughput analysis of clinical samples of ivacaftor, its major metabolites, and lumacaftor in biological fluids of cystic fibrosis patients. JOVE 128:1–7

Google Scholar 

Schneider EK, Reyes-Ortega F, Wilson JW, Kotsimbos T, Keating D, Li J, Velkov T (2016) Development of HPLC and LC–MS/MS methods for the analysis of ivacaftor, its major metabolites and lumacaftor in plasma and sputum of cystic fibrosis patients treated with ORKAMBI or KALYDECO. J Chromatogr B 1038:57–62

Article  CAS  Google Scholar 

Zheng Y, Rouilon S, Khemakhem M, Balakirouchenane D, Luig AS, Sanoufi MR, Sauvaitre L, Thebault L, Hirt D (2024) A rapid LC-MS/MS method for the simultaneous quantification of ivacaftor, lumacaftor, elexacaftor, tezacaftor, hexyl-methyl ivacaftor and ivacaftor carboxylate in human plasma. J Pharm Biomed Anal 248:116322

Article  CAS  PubMed  Google Scholar 

Sonawane M, Gade S, Narwate B (2018) Application and UV spectrophotometric method development and validation for simultaneous estimation of tezacaftor and ivacaftor in pharmaceutical dosage form. World J Pharm Res 7:213–219

Google Scholar 

Shah PA, Shrivastav PS, Sharma V, Yadav MS (2019) Challenges in simultaneous extraction and chromatographic separation of metformin and three SGLT-2 inhibitors in human plasma using LC–MS/MS. J Pharm Biomed Anal 175:112790

Article  CAS  PubMed  Google Scholar 

International Conference on Harmonisation Harmonised Tripartite Guideline (2005) Validation of analytical procedures: text and methodology Q2 (R1). ICH, Geneva.

Zwir-Ferenc A, Biziuk M (2006) Solid phase extraction technique—Trends, opportunities and applications. Polish J Environ Stud 15:677–690

CAS  Google Scholar 

Gałuszka A, Migaszewski ZM, Konieczka P, Namieśnik J (2012) Analytical eco-scale for assessing the greenness of analytical proce dures. TrAC Trends Anal Chem 37:61–72

Article  Google Scholar 

Płotka-Wasylka J, Wojnowski W (2021) Complementary green analytical procedure index (ComplexGAPI) and software. Green Chem 23:8657–8665

Article  Google Scholar 

Pena-Pereira F, Wojnowski W, Tobiszewski M (2020) AGREE analytical GREEnness metric approach and software. Anal Chem 92:10076–10082

Article  CAS  PubMed  PubMed Central  Google Scholar